Table 1.

Clinical and demographic information

CharacteristicsAN (n = 22)BN (n = 33)HC (n = 30)Analysis
MeanSDMeanSDMeanSDΧ2(df), F(df), W, t(df)p Value
Age (years)24.64.723.63.923.93.5Χ2(2) = 0.80.69
BMI (kg/m2)16.41.422.02.421.92.1Χ2(2) = 48.4<0.001
IQa116511451145Χ2(2) = 3.20.21
Age of onset (years)15.62.416.23.1t(51.8) = −0.80.42
Illness duration (years)9.05.87.44.0t(34.4) = 1.10.27
Beck Depression Inventory35.312.032.710.52.42.8Χ2(2) = 57.7<0.001
Trait Anxiety Inventory63.110.462.87.333.06.9F(2) = 151.1<0.001
Barratt Impulsiveness Scale66.214.068.411.156.76.3F(2) = 10.4<0.001
Eating Disorder Examination Questionnaire4.40.84.60.80.20.2Χ2(2) = 58.0<0.001
Eating disorder examination ratingsb
Objective binge-eating episodes38.147.923.029.1W = 317.50.43
Subjective binge-eating episodes9.512.86.66.2W = 341.50.93
Vomiting episodes43.551.624.231.0W = 304.00.31
Laxative episodes1.13.42.03.9W = 421.50.18
Exercise episodes7.413.610.99.4W = 478.50.04
N%N%N%Χ2(df)p Value
Comorbid diagnoses
Anxiety disorder313.639.1Χ2(1) = 0.30.69
Major depressive episode1568.21648.5Χ2(1) = 2.10.15
Personality disorder29.1515.2Χ2(1) = 0.40.69
Any current treatment1359.01545.5Χ2(1) = 1.00.32
Psychotherapy940.9927.3Χ2(1) = 1.10.29
Medication1045.51030.3Χ2(1) = 1.30.25
Prior restrictive AN1463.61030.3Χ2(1) = 6.00.01
  • Group differences were evaluated using one-way ANOVA and, for non-normally distributed data, the nonparametric Kruskal–Wallis test. The two-samples t test (two-sided), Mann–Whitney U test, and χ2 test were used to assess differences between AN and BN groups. For type and dose of prescribed medications, see Extended data Table 1-1.

  • aEstimated full-scale IQ from the National Adult Reading Test.

  • bED examination ratings reflect counts over the previous 28 d.